Yumanity Therapeutics Sees Lead Candidate Interim Data From Early-Stage Parkinson's Study By Mid-2021
Opiant Pharma Advances OPNT003 PK Study With First Patient Dosing
Orchard Therapeutics' MPS-I Gene Therapy Shows Encouraging Action In Early Study, Shares Spike
Getting Into The Drug Business: From NDAs To PDUFA Dates